[
    [
        {
            "time": "2021-05-17",
            "original_text": "高瓴资本最新A股持仓标的，从行业来看，依然看好新能源、医药以及消费等领域",
            "features": {
                "keywords": [
                    "高瓴资本",
                    "A股",
                    "新能源",
                    "医药",
                    "消费"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "新能源",
                    "医药",
                    "消费"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "高瓴资本最新A股持仓标的，从行业来看，依然看好新能源、医药以及消费等领域",
                "Correlation": 7,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 6,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "亚辉龙生物登陆科创板，开盘涨幅超300% | 强生上市全球首款治疗性隐形眼镜",
            "features": {
                "keywords": [
                    "亚辉龙生物",
                    "科创板",
                    "强生",
                    "隐形眼镜"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "亚辉龙生物登陆科创板，开盘涨幅超300% | 强生上市全球首款治疗性隐形眼镜",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 9,
                "Duration": 7,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 9,
                "Headline_Structure": 9,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "乐普拟将创新业务分拆上市，支架企业纷纷加入分拆热潮",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "分拆上市",
                    "创新业务",
                    "支架企业"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普拟将创新业务分拆上市，支架企业纷纷加入分拆热潮",
                "Correlation": 8,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 8,
                "Entity_Density": 7,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "港股IPO|乐普医疗拟分拆心泰科技赴港上市，2020年归母净利润为6968万元人民币",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心泰科技",
                    "港股IPO",
                    "净利润"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "港股IPO|乐普医疗拟分拆心泰科技赴港上市，2020年归母净利润为6968万元人民币",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 9,
                "Market_Scope": 5,
                "Time_Proximity": 8,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "国信证券：当前应在医药各细分领域中优选一、二线公司中内生成长明确的标的",
            "features": {
                "keywords": [
                    "国信证券",
                    "医药",
                    "内生成长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": "none"
            },
            "scores": {
                "News_content": "国信证券：当前应在医药各细分领域中优选一、二线公司中内生成长明确的标的",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 6,
                "Impact": 5,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 6,
                "Headline_Structure": 5,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "医药行业一周观察：医药板块强势反弹 关注疫苗及全球化创新",
            "features": {
                "keywords": [
                    "医药行业",
                    "反弹",
                    "疫苗",
                    "全球化创新"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医药行业一周观察：医药板块强势反弹 关注疫苗及全球化创新",
                "Correlation": 7,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "两家知名药企高管离职！董监高成员变化",
            "features": {
                "keywords": [
                    "药企",
                    "高管离职",
                    "董监高"
                ],
                "sentiment_score": -0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "两家知名药企高管离职！董监高成员变化",
                "Correlation": 6,
                "Sentiment": 4,
                "Importance": 6,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 6,
                "Market_Scope": 7,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "医疗器械板块强势领涨，“医械茅”迈瑞医疗大涨近6%",
            "features": {
                "keywords": [
                    "医疗器械",
                    "迈瑞医疗",
                    "领涨"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "医疗器械板块强势领涨，“医械茅”迈瑞医疗大涨近6%",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 8,
                "Duration": 6,
                "Entity_Density": 8,
                "Market_Scope": 8,
                "Time_Proximity": 8,
                "Headline_Structure": 9,
                "Source_Recency": 8
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "乐普医疗：拟将心泰科技至香港联交所主板上市",
            "features": {
                "keywords": [
                    "乐普医疗",
                    "心泰科技",
                    "香港联交所"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医疗器械"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "乐普医疗：拟将心泰科技至香港联交所主板上市",
                "Correlation": 10,
                "Sentiment": 7,
                "Importance": 9,
                "Impact": 8,
                "Duration": 9,
                "Entity_Density": 10,
                "Market_Scope": 5,
                "Time_Proximity": 9,
                "Headline_Structure": 7,
                "Source_Recency": 9
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "和讯SGI指数TOP30出炉! 迈瑞医疗、中望软件、乐普医疗包揽前三",
            "features": {
                "keywords": [
                    "和讯SGI指数",
                    "迈瑞医疗",
                    "中望软件",
                    "乐普医疗"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "医疗器械",
                    "软件"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "和讯SGI指数TOP30出炉! 迈瑞医疗、中望软件、乐普医疗包揽前三",
                "Correlation": 8,
                "Sentiment": 8,
                "Importance": 7,
                "Impact": 6,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 9,
                "Source_Recency": 7
            }
        },
        {
            "time": "2021-05-17",
            "original_text": "国际新冠试剂市场新一轮洗牌开启，无“自测证书”产品或受影响，需求将向少数公司集中",
            "features": {
                "keywords": [
                    "新冠试剂",
                    "自测证书",
                    "市场需求"
                ],
                "sentiment_score": -0.4,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "国际新冠试剂市场新一轮洗牌开启，无“自测证书”产品或受影响，需求将向少数公司集中",
                "Correlation": 7,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 9,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 7
            }
        }
    ]
]